Equities

Verici DX PLC

VRCI:LSE

Verici DX PLC

Health CarePharmaceuticals and Biotechnology
  • Price (GBX)0.725
  • Today's Change0.00 / 0.00%
  • Shares traded887.17k
  • 1 Year change-80.67%
  • Beta0.3790
Data delayed at least 20 minutes, as of Feb 06 2026 16:17 GMT.
More ▼

Financials data is unavailable for this security.

Cash flow in USDView more

In 2024, Verici DX PLC increased its cash reserves by 53.53%, or 1.42m. Cash Flow from Financing totalled 7.32m or 219.29% of revenues. In addition the company used 6.02m for operations while cash from investing totalled 61.00k.
Cash flow per share-0.0212
Price/Cash flow per share--
Book value per share0.0075
Tangible book value per share0.001
More ▼

Balance sheet in USDView more

Verici DX PLC appears to have little financial risk as the company holds a substantial amount of cash on its books. In fact, 0.37% of the market capitalization can be attributed to its 4.06m and debt could be paid in full if management chose.
Current ratio0.9095
Quick ratio--
Total debt/total equity0.1136
Total debt/total capital0.102
More ▼
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.